NEW YORK (GenomeWeb) – Roche announced on Monday that its Cobas methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus (SA) nucleic acid test has received CE-IVD marking for use on the firm's Liat PCR point-of-care platform.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.